Sorry, you need to enable JavaScript to visit this website.

Title: Section 2.1 - Communicable diseases designated: cases, suspected cases and certain carriers to be reported to the State Department of Health

Effective Date

12/20/2023

DESIGNATION OF CASES
Section 2.1.

Communicable diseases designated: cases, suspected cases and certain carriers to be reported to the State Department of Health.

(a) When used in the Public Health Law and in this Chapter, the term infectious, contagious or communicable disease, shall be held to include the following diseases and any other disease which the commissioner, in the reasonable exercise of his or her medical judgment, determines to be communicable, rapidly emergent or a significant threat to public health, provided that the disease which is added to this list solely by the commissioner’s authority shall remain on the list only if confirmed by the Public Health and Health Planning Council at its next scheduled meeting:

Amebiasis

Anthrax

Arboviral infection

Babesiosis

Botulism

Brucellosis

Campylobacteriosis

Chancroid

Chlamydia trachomatis infection

Cholera

Cryptosporidiosis

Cyclosporiasis

Diphtheria

E. coli 0157:H7 infections

Ehrlichiosis

Encephalitis

Giardiasis

Glanders

Gonococcal infection

Group A Streptococcal invasive disease

Group B Streptococcal invasive disease

Hantavirus disease

Hemolytic uremic syndrome

Hemophilus influenzae (invasive disease)

Hepatitis (A; B; C)

Herpes infection in infants aged 60 days or younger (neonatal)

Hospital-associated infections (as defined in section 2.2 of this Part)

Influenza (laboratory-confirmed)

Legionellosis

Listeriosis

Lyme disease

Lymphogranuloma venereum

Malaria

Measles

Melioidosis

Meningitis

           Aseptic

           Hemophilus

           Meningococcal

           Other (specify type)

Meningococcemia

Mpox

Mumps

Pertussis (whooping cough)

Plague

Poliomyelitis

Psittacosis

Q Fever

Rabies

Respiratory syncytial virus (RSV) (laboratory confirmed cases of RSV or deaths caused by laboratory confirmed RSV in persons younger than 18 years)

Rocky Mountain spotted fever

Rubella

Congenital rubella syndrome

Salmonellosis

Severe or novel coronavirus

           Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), including Pediatric Multi-system Inflammatory Syndrome, or any other complication suspected of being associated with SARS-CoV-2 infection

           Severe Acute Respiratory Syndrome (SARS)

           Middle East Respiratory Syndrome (MERS)

           Other (specify type)

Shigellosis

Smallpox

Staphylococcal enterotoxin B poisoning

Streptococcus pneumoniae invasive disease

Syphilis, specify stage

Tetanus

Toxic Shock Syndrome

Trichinosis

Tuberculosis, current disease (specify site)

Tularemia

Typhoid

Varicella (not zoster/shingles)

Vaccinia disease: (as defined in Section 2.2 of this Part)

Viral hemorrhagic fever

Yersiniosis

(b) Upon receipt of a report made pursuant to section 2.10, the city, county or district health officer shall retain a copy in his record of the reports of such communicable diseases as the State Commissioner of Health may direct, and shall retain these copies until their destruction is authorized by the State Commissioner of Health, and shall forward a copy of all reports immediately to the State Department of Health. In lieu of an individual report of each case, the city, county or district health officer may, with the written consent of the State Commissioner of Health, make such summarized reports as the commissioner may require.

(c) Any disease outbreak or unusual disease shall also be reported to the State Department of Health as provided in subdivision (b) of this section. Unusual disease is defined as a newly apparent or emerging disease or syndrome of uncertain etiology that a health care provider or the State Commissioner of Health has reason to believe could possibly be caused by a transmissible infectious agent or microbial toxin.

Volume

VOLUME A (Title 10)

up